Edita Griniutė- Mištinienė PhD
CEO at Profarma
Dr. Edita Griniutė- Mištinienė is founder and CEO of Profarma, pharmaceutical company providing Quality Control testing services as well as R&D. Edita has experience in biopharma industry for more than 20 years, at different R&D and management positions.
From 2009 to 2014 she held positions of R&D and Biosimilars Director, Chief Scientific Officer and Member of Board of Directors at 3P Biopharmaceuticals (Spain), where she developed infrastructure for research and development unit, managed innovative and biosimilars R&D projects at different phases from proof-of-concept stage to clinical trials. In parallel she was one of co-founders of Profarma and provided contribution to its R&D activities, including now patented ProMER technology development. Before that, she was Head of R&D at TEVA Pharmaceuticals/Sicor for 10 years, where she led a number of innovative and biosimilar R&D projects according to EMA and FDA requirements.
Education: Biochemistry master’s degree in Vilnius university, PhD studies in Institute of Biotechnology, Vilnius (2004).